Zhuo Xu, Naixia Zhang, Li Shi: Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them. Am J Cancer Res 2024;14(6):2666-2694. (Full text, PDF)
Xiang Li, Xu Yang, Wei Guo, Hao Li, Weiqing Sun, Xingda Lin, Zuoxin Ma, Xuan Li, Zhe Liu: Natural products as inhibitors against pancreatic cancer cell proliferation and invasion: possible mechanisms. Am J Cancer Res 2024;14(6):2695-2713. (Full text, PDF)
Fengkuo Xu, Zhigang Wei, Xin Ye: Immunomodulatory effects of microwave ablation on malignant tumors. Am J Cancer Res 2024;14(6):2714-2730. (Full text, PDF)
Liangbin Lin, Hui Yu, Xuelu Xie, Qingqiang Lei, Xuerui Chen, Xu Su, Xiuxuan Wang, Sunfu Zhang, Wenyong Yang: Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcome. Am J Cancer Res 2024;14(6):2731-2754. (Full text, PDF, Tables S2, S3)
Jianlong Xie, Yongfang Ou, Qiujuan Fu, Zhirong Ye, Yonghua Chen, Ziyi Yang, Liyao Lin, Qin Wu, Dong Wu, Rijian Gan, Junfeng Wang, Qinhui Luo, Kaiqi Zeng, Huilai Miao: Taraxasterol exhibits dual biological effects on anti-aging and anti-cancer in lung cells. Am J Cancer Res 2024;14(6):2755-2769. (Full text, PDF)
Wei He, Suotian Liu, Wei Wei, Run Qin, Jinfeng Tan, Jie Tang, Zhenglan Huang, Miao Gao: mTOR inhibition by AZD2014 alleviates BCR::ABL1 independent imatinib resistance through enhancing autophagy in CML resistant cells. Am J Cancer Res 2024;14(6):2770-2789. (Full text, PDF)
Zongjiong Mai, Yanyu Li, Lei Zhang, Hongyu Zhang: Citraconate promotes the malignant progression of colorectal cancer by inhibiting ferroptosis. Am J Cancer Res 2024;14(6):2790-2804. (Full text, PDF)
Chenxiao Bi, Chengyu Li, Liangxiu Xing, Zixuan Lu, Haiyan Liu, Tao Hu, Bin Wang, Chengxia Liu: Extracellular putrescine can augment the epithelial-mesenchymal transition of gastric cancer cells by promoting MAL2 expression by elevating H3K27ac in its promoter region. Am J Cancer Res 2024;14(6):2805-2822. (Full text, PDF)
Wuguang Chang, Wuyou Gao, Die Liu, Bin Luo, Hongmu Li, Leqi Zhong, Youfang Chen: The upregulation of TGM2 is associated with poor prognosis and the shaping of the inflammatory tumor microenvironment in lung squamous cell carcinoma. Am J Cancer Res 2024;14(6):2823-2838. (Full text, PDF)
Hung-Chih Hsu, Yun-Shien Lee, Titilianty I Imbang, Ting-Chia Liu, Shuen-Iu Hung: SLC11A1 predicts the overall survival of patients with colorectal cancer. Am J Cancer Res 2024;14(6):2839-2851. (Full text, PDF)
Wei Zhou, Xingquan Li, Bolin Zhang, Hong Peng, Chunyang Quan, Xin Xiao, Man Luo, Yanxiao Huang, Debin Xu, Kai Huang, Qifang Jin, Shan Lu: The long non-coding RNA CCAT1 promotes erlotinib resistance in cholangiocarcinoma by inducing epithelial-mesenchymal transition via the miR-181a-5p/ROCK2 axis. Am J Cancer Res 2024;14(6):2852-2867. (Full text, PDF)
Ting Wang, Shan Wang, Tao Wang, Lintao Jia, Gang Nan, Liang Wang: Cdc14B/Cyclin B1 signaling modulates the pathogenesis of sonic hedgehog subtype medulloblastoma. Am J Cancer Res 2024;14(6):2868-2880. (Full text, PDF)
Shilong Liu, Lili Liu, Jianli Ma, Jian Li, Liqun Wang, Jianyu Xu, Songliu Hu: αPD-1 immunotherapy promotes IL-17A production and promotes the formation of acute radiation-induced lung injury. Am J Cancer Res 2024;14(6):2881-2893. (Full text, PDF)
Sicong Jiang, Xuefeng Wang, Yuxuan Xing, Jiahao Wu, Xiya Yuan: Value of prognostic nutritional index and controlling nutritional status score for advanced non-small cell lung cancer patients receiving PD-1 inhibitors. Am J Cancer Res 2024;14(6):2894-2904. (Full text, PDF)
Tom van Meerten, John Kuruvilla, Kevin W Song, Catherine Thieblemont, Monique C Minnema, Edouard Forcade, Sophie De Guibert, Marie José Kersten, Pim GNJ Mutsaers, Martin Wermke, Yan Zheng, Allen Xue, Joshua N Winters, Jenny Nater, Rhine R Shen, Clare Spooner, Frank Neumann, Jenny J Kim, Max S Topp: Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphoma. Am J Cancer Res 2024;14(6):2905-2920. (Full text, PDF)
Pengpeng Liu, Xiaohang Hang, Jianjun Li, Lei Zhao, Weiping Liu, Jie Ji, Yu Wu, Xudong Wan, Xiao Shuai, Yong Guo, Bing Xiang, Jiazhuo Liu, Jie Huang, Zhigang Liu, Li Hou, Chong Chen, Yu Liu, Ting Liu: Chidamide represses MYC expression and might improve survival for patients with double expressor lymphoma. Am J Cancer Res 2024;14(6):2921-2933. (Full text, PDF)
Xuan Ma, Xuean Zhu, Mingli Zou, Jingjing Zhang, Lili Huang, Shasha Jiang, Yanan Zhi: Expression of CXCL8 and its relationship with prognosis in patients with non-small cell lung cancer. Am J Cancer Res 2024;14(6):2934-2945. (Full text, PDF)
Haining Xu, Jianliang Tian, Liang Li, Fang Liu, Yuebing Ren, Guangming Guo, Qian Peng: Risk factors for the outcome and prognosis of multiple myeloma patients with pathological fractures undergoing percutaneous vertebroplasty. Am J Cancer Res 2024;14(6):2946-2956. (Full text, PDF)
Chih-Hsien Yu, Kuan-Chou Lin, Chia-Lun Chang, Wan-Ming Chen, Ben-Chang Shia, Szu-Yuan Wu: Statin therapy enhances survival in unresectable stage III lung squamous cell carcinoma with concurrent chemoradiotherapy. Am J Cancer Res 2024;14(6):2957-2970. (Full text, PDF)
Xubin Ji, Tianyan Li, Fang Liu, Yanmin Zhao, Liang Li, Guangming Guo, Minya Dong, Xuede Gao: Curettage of lesion combined with reconstruction of intramedullary nail and bone cement for the treatment of subtrochanteric metastatic tumors of the femur. Am J Cancer Res 2024;14(6):2971-2983. (Full text, PDF)
Hsuan-Hwai Lin, Yi-Jen Peng, Chao-Feng Chang, Ping-Ying Chang, Ping-Chi Peng, Wei-Chou Chang, Teng-Wei Chen, Tsai-Yuan Hsieh: Heterogenous liver parenchymal enhancement in CT is a favorable prognosis of HCC after hepatic resection. Am J Cancer Res 2024;14(6):2984-2993. (Full text, PDF)
Huange Xue, Yufei Ma, Kaiwen Guan, Yueyang Zhou, Yang Liu, Fei Cao, Xiaohong Kang: The role of m6A methylation in targeted therapy resistance in lung cancer. Am J Cancer Res 2024;14(6):2994-3009. (Full text, PDF)
Prateeti Srivastava, Vijesh Kumar Yadav, Tzu-Hao Chang, Emily Chia-Yu Su, Bashir Lawal, Alexander TH Wu, Hsu-Shan Huang: In-silico analysis of TMEM2 as a pancreatic adenocarcinoma and cancer-associated fibroblast biomarker, and functional characterization of NSC777201, for targeted drug development. Am J Cancer Res 2024;14(6):3010-3035. (Full text, PDF)
Mateusz Olbromski, Monika Mrozowska, Aleksandra Piotrowska, Alicja Kmiecik, Beata Smolarz, Hanna Romanowicz, Piotr Blasiak, Adam Maciejczyk, Andrzej Wojnar, Piotr Dziegiel: Prognostic significance of alpha-2-macrglobulin and low-density lipoprotein receptor-related protein-1 in various cancers. Am J Cancer Res 2024;14(6):3036-3058. (Full text, PDF)
Shuguang Li, Shuai Liu, Shanzhou Fang, Feifei Zhao: Establishment and verification of a predictive model for bone metastasis in patients with non-small cell lung cancer based on peripheral blood CX3CL and CCL28. Am J Cancer Res 2024;14(6):3059-3067. (Full text, PDF)
Harold Salamanca-Ortiz, Guadalupe Domínguez-Gomez, Alma Chávez-Blanco, Daniel Ortega-Bernal, José Díaz-Chávez, Aurora González-Fierro, Myrna Candelaria-Hernández, Alfonso Dueñas-González: The inhibitory and transcriptional effects of the epigenetic repurposed drugs hydralazine and valproate in lymphoma cells. Am J Cancer Res 2024;14(6):3068-3082. (Full text, PDF, Supplementary Tables 1, 2, 3, 4)
Raed Sulaiman, Jennifer C Aske, Luis Rojas Espaillat, Xiaoqian Lin, David Starks, Adam Dale, Kris Gaster, Pradip De, Nandini Dey: Ex vivo platform en route to functional precision medicine: clinical relevance in gynecological cancers. Am J Cancer Res 2024;14(6):3083-3103. (Full text, PDF)
Wanzhi Chen, Jichun Yu, Kunlin Lei, Rong Xie, Haiyan Wang, Meijun Zhong: Analysis of risk factors for lymph node metastasis in 241 patients with thyroid carcinoma and establishment of a prediction model. Am J Cancer Res 2024;14(6):3104-3116. (Full text, PDF)
Zhiqiang Liu, Liang Li, Lei Liu, Zhengming Zhu, Yi Yu, Shaochao Zhan, Zepeng Luo, Yuchen Li, He Long, Jing Cai, Kai Huang, Xiaohong Du: PDK3 drives colorectal carcinogenesis and immune evasion and is a therapeutic target for boosting immunotherapy. Am J Cancer Res 2024;14(6):3117-3129. (Full text, PDF)
Yi Jiang, Chaoping Wang, Jiali Shen: Predictive value of dynamic changes in peripheral blood inflammation and blood lipid-related indices for the lung cancer treatment efficacy. Am J Cancer Res 2024;14(6):3130-3141. (Full text, PDF)
Yongliang Liu, Yan Li, Ying Hou, Zhenan Zhao, Guoquan Wang, Chunmiao Gao, Yuqing Sun, Na Li, Yan Jiang: The use of adjuvant chemotherapy combined with concurrent chemoradiotherapy enhances survival rates in cases of locally advanced nasopharyngeal carcinoma. Am J Cancer Res 2024;14(6):3142-3152. (Full text, PDF)
Wei Lin, Wei-Chun Wu, Zhi Liang, Jian-Hao Zhang, Shi-Peng Fang: LncRNA FEZF1-AS1 facilitates cisplatin resistance in non-small cell lung cancer through modulating the miR-32-5p-glutaminase axis. Am J Cancer Res 2024;14(6):3153-3170. (Full text, PDF)
Yen-Liang Li, Chung-Hsing Chen, You-Syuan Lai, Mei-Ren Pan, Wen-Chun Hung: Increased blood CSF3R+ myeloid-derived suppressor cell is a predictor for breast cancer recurrence. Am J Cancer Res 2024;14(6):3171-3185. (Full text, PDF)
Gwan Hee Han, Hae-Rim Kim, Hee Yun, Joon-Yong Chung, Jae-Hoon Kim, Hanbyoul Cho: Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning. Am J Cancer Res 2024;14(6):3186-3197. (Full text, PDF)
Bashir Lawal, Yu-Cheng Kuo, Alexander TH Wu, Hsu-Shan Huang: Therapeutic potential of EGFR/mTOR/Nf-kb targeting small molecule for the treatment of non-small cell lung cancer: Am J Cancer Res. 2023; 13(6): 2598-2616. Am J Cancer Res 2024;14(6):3198-3199. (Full text, PDF)
